Benjamin Machinas Beneski
SVP, Chief Technical Officer · Allogene Therapeutics, Inc.
- 2025
- Apr 2, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Benjamin Machinas Beneski files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- David D. Chang - $289K in ALLO purchases and sales in the last 12 months
- Zachary Roberts - $104K in ALLO purchases and sales in the last 12 months
- Earl Martin Douglas - $103K in ALLO purchases and sales in the last 12 months
- Geoffrey M. Parker - $88K in ALLO purchases and sales in the last 12 months
- Annie Yoshiyama - $29K in ALLO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Benjamin Machinas Beneski?
Benjamin Machinas Beneski is a corporate insider, tracked as SVP, Chief Technical Officer of Allogene Therapeutics, Inc. (ALLO). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Benjamin Machinas Beneski last file a Form 4?
The most recent primary Form 4 on record is dated 2 April 2026, one of 5 filings going back to 2025.
Has Benjamin Machinas Beneski been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($52K) across all tracked filings.
